Embed this press release by copying the code below:
NASDAQ:IMMU Long Term Investor Notice: Investigation of Potential Wrongdoing at Immunomedics, Inc.
NASDAQ:IMMU Long Term Investor Notice: Investigation of Potential Wrongdoing at Immunomedics, Inc.